Annual Current Ratio
9.93
-10.42-51.20%
December 31, 2023
Summary
- As of February 6, 2025, XTLB annual current ratio is 9.93, with the most recent change of -10.42 (-51.20%) on December 31, 2023.
- During the last 3 years, XTLB annual current ratio has fallen by -14.17 (-58.80%).
- XTLB annual current ratio is now -69.34% below its all-time high of 32.39, reached on December 31, 2018.
Performance
XTLB Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Ratio
0.81
-11.42-93.38%
September 30, 2024
Summary
- As of February 6, 2025, XTLB quarterly current ratio is 0.81, with the most recent change of -11.42 (-93.38%) on September 30, 2024.
- Over the past year, XTLB quarterly current ratio has dropped by -10.62 (-92.91%).
- XTLB quarterly current ratio is now -98.41% below its all-time high of 51.07, reached on March 1, 2019.
Performance
XTLB Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Ratio Formula
Current Ratio = Current Assets
Current Liabilities
Current Assets
Current Liabilities
Current Liabilities
XTLB Current Ratio Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -51.2% | -92.9% |
3 y3 years | -58.8% | -92.9% |
5 y5 years | -69.3% | -97.5% |
XTLB Current Ratio Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -63.2% | at low | -97.4% | at low |
5 y | 5-year | -66.3% | at low | -97.7% | at low |
alltime | all time | -69.3% | +331.7% | -98.4% | +268.2% |
XTL Biopharmaceuticals Current Ratio History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | 0.81(-93.4%) |
Jun 2024 | - | 12.23(+7.0%) |
Mar 2024 | - | 11.43(+15.1%) |
Dec 2023 | 9.93(-51.2%) | 9.93(-29.5%) |
Sep 2023 | - | 14.09(-8.1%) |
Jun 2023 | - | 15.34(+25.6%) |
Mar 2023 | - | 12.21(-40.0%) |
Dec 2022 | 20.35(-24.6%) | 20.35(-31.1%) |
Sep 2022 | - | 29.52(-5.6%) |
Jun 2022 | - | 31.26(+30.3%) |
Mar 2022 | - | 24.00(-11.1%) |
Dec 2021 | 27.00(+12.0%) | 27.00(-22.8%) |
Sep 2021 | - | 34.99(+37.4%) |
Jun 2021 | - | 25.47(-7.8%) |
Mar 2021 | - | 27.61(+14.6%) |
Dec 2020 | 24.10(-18.1%) | 24.10(-24.7%) |
Sep 2020 | - | 32.02(-3.1%) |
Jun 2020 | - | 33.03(+17.0%) |
Mar 2020 | - | 28.23(-4.1%) |
Dec 2019 | 29.44(-9.1%) | 29.44(-25.5%) |
Sep 2019 | - | 39.54(-12.4%) |
Jun 2019 | - | 45.15(-11.6%) |
Mar 2019 | - | 51.07(+57.7%) |
Dec 2018 | 32.39(+56.5%) | 32.39(-10.0%) |
Sep 2018 | - | 35.98(+17.6%) |
Jun 2018 | - | 30.59(+17.3%) |
Mar 2018 | - | 26.07(+26.0%) |
Dec 2017 | 20.69(+147.8%) | 20.69(-8.2%) |
Sep 2017 | - | 22.53(+26.7%) |
Jun 2017 | - | 17.78(+30.6%) |
Mar 2017 | - | 13.61(+63.0%) |
Dec 2016 | 8.35 | 8.35(-33.0%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2016 | - | 12.47(+27.5%) |
Dec 2015 | 9.78(+204.7%) | 9.78(-46.8%) |
Sep 2015 | - | 18.39(-19.2%) |
Jun 2015 | - | 22.76(+609.0%) |
Dec 2014 | 3.21(-23.0%) | 3.21(-2.4%) |
Sep 2014 | - | 3.29(+0.3%) |
Jun 2014 | - | 3.28(-10.6%) |
Mar 2014 | - | 3.67(-12.0%) |
Dec 2013 | 4.17(+81.3%) | 4.17(-3.0%) |
Sep 2013 | - | 4.30(+126.3%) |
Jun 2013 | - | 1.90(-10.0%) |
Mar 2013 | - | 2.11(-8.3%) |
Dec 2012 | 2.30(-11.2%) | 2.30(-50.5%) |
Sep 2012 | - | 4.65(+6.9%) |
Jun 2012 | - | 4.35(+6.4%) |
Mar 2012 | - | 4.09(+41.5%) |
Sep 2011 | - | 2.89(-8.5%) |
Jun 2011 | - | 3.16(+1.3%) |
Mar 2011 | - | 3.12(+98.7%) |
Sep 2010 | - | 1.57(+613.6%) |
Jun 2010 | - | 0.22(-52.2%) |
Mar 2010 | - | 0.46(-61.0%) |
Sep 2009 | - | 1.18(-16.3%) |
Jun 2008 | - | 1.41(-45.6%) |
Dec 2007 | 2.59(-66.2%) | 2.59(-20.3%) |
Jun 2007 | - | 3.25(-57.6%) |
Dec 2006 | 7.67(+33.9%) | 7.67(-27.4%) |
Jun 2006 | - | 10.57(+84.5%) |
Dec 2005 | 5.73(-14.9%) | 5.73(-5.1%) |
Jun 2005 | - | 6.04(-10.3%) |
Dec 2004 | 6.73(-12.0%) | 6.73(+80.9%) |
Jun 2004 | - | 3.72 |
Dec 2003 | 7.65 | - |
FAQ
- What is XTL Biopharmaceuticals annual current ratio?
- What is the all time high annual current ratio for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals annual current ratio year-on-year change?
- What is XTL Biopharmaceuticals quarterly current ratio?
- What is the all time high quarterly current ratio for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals quarterly current ratio year-on-year change?
What is XTL Biopharmaceuticals annual current ratio?
The current annual current ratio of XTLB is 9.93
What is the all time high annual current ratio for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual current ratio is 32.39
What is XTL Biopharmaceuticals annual current ratio year-on-year change?
Over the past year, XTLB annual current ratio has changed by -10.42 (-51.20%)
What is XTL Biopharmaceuticals quarterly current ratio?
The current quarterly current ratio of XTLB is 0.81
What is the all time high quarterly current ratio for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly current ratio is 51.07
What is XTL Biopharmaceuticals quarterly current ratio year-on-year change?
Over the past year, XTLB quarterly current ratio has changed by -10.62 (-92.91%)